Category: ETFs |
Launch Date: 09-11-2011 |
Asset Class: |
Benchmark: Domestic Price of Gold |
TER: 0.41% As on (30-11-2024) |
Status: Open Ended Schemes |
Minimum Investment: 10000.0 |
Minimum Topup: 0.0 |
Total Assets: 170.02 Cr As on 29-11-2024(Source:AMFI) |
Turn over: - | Exit Load: Nil |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The fund aims to provide returns that closely correspond to the return provided by the price of gold through investment in physical gold in domestic market. The reason for performance variance of the scheme from that of domestic price of gold may be due to expense and other related factors.
Standard Deviation | 11.84 |
Sharpe Ratio | 0.68 |
Alpha | -0.3 |
Beta | 1.02 |
Yield to Maturity | |
Average Maturity |
Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
---|---|---|---|---|---|---|
LIC MF Gold Exchange Traded Fund | 09-11-2011 | 20.18 | 16.55 | 15.44 | 14.07 | 10.14 |
Mirae Asset NYSE FANG and ETF | 01-05-2021 | 56.82 | 72.92 | 27.63 | - | - |
Motilal Oswal BSE Healthcare ETF | 29-07-2022 | 46.96 | 38.68 | - | - | - |
Aditya Birla Sun Life Nifty Healthcare ETF | 05-10-2021 | 43.4 | 35.26 | 21.22 | - | - |
ICICI Prudential Nifty Healthcare ETF | 05-05-2021 | 42.75 | 34.92 | 21.0 | - | - |
Axis NIFTY Healthcare ETF | 17-05-2021 | 42.44 | 34.65 | 20.77 | - | - |
Nippon India Nifty Pharma ETF | 05-07-2021 | 40.08 | 34.2 | 20.14 | - | - |
Mirae Asset S&P 500 Top 50 ETF | 25-09-2021 | 38.37 | 37.15 | 16.92 | - | - |
Tata Nifty India Digital Exchange Traded Fund | 30-03-2022 | 38.14 | 34.87 | - | - | - |
Kotak Nifty Alpha 50 ETF | 22-12-2021 | 36.96 | 35.33 | - | - | - |
Others
100.0%